Overview


According to FutureWise analysis the market for Atrial Fibrillation is expected to reach US$ 3.52 billion by 2031 at a CAGR of 6.62%.

Atrial fibrillation is a type of cardiac arrhythmia affecting millions worldwide. The condition is caused by abnormal electrical signals in the heart, which make the atria (the heart's upper chambers) quiver or fibrillate instead of contracting normally. It is characterized by an irregular and rapid heartbeat that can lead to various cardiovascular complications such as stroke and heart failure. The condition is associated with several risk factors, such as aging, high blood pressure, diabetes, and obesity. Common symptoms of AF may include palpitations or a rapid or irregular heartbeat, fatigue or weakness, difficulty breathing or shortness of breath, discomfort, chest pain, dizziness, and fainting or loss of consciousness. The diagnosis of AF is typically based on an electrocardiogram (ECG), which can detect irregular heart rhythms. Other tests, such as a Holter monitor or event recorder, may be used to monitor the heart rhythm over a period of time.

The global atrial fibrillation market is driven by the increasing prevalence of AF and the growing demand for effective and minimally invasive treatment options. The market players are focusing on developing innovative products and technologies to cater to the unmet needs of AF patients and improve the outcomes of AF treatment. The atrial fibrillation market includes various treatment options, such as anti-arrhythmic drugs, anticoagulants, electrical cardioversion, catheter ablation, and surgical ablation. Anti-arrhythmic drugs are the most commonly used treatment option for AF, but they have limited efficacy and are associated with various side effects. Anticoagulants are used to prevent stroke in AF patients, but they can also increase the risk of bleeding.

FutureWise Market Research has published a report that provides an insightful analysis of Atrial Fibrillation Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Atrial Fibrillation Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Abbott Laboratories
  • Johnson And Johnson
  • MicroPort Scientific Corporation
  • Boston Scientific Corporation
  • BCN Peptides S.A.
  • St. Jude Medical, Inc.
  • Medtronic plc
  • Biotronik SECo. KG
  • Koninklijke Philips N.V.
  • Siemens AG
  • AtriCure Inc.
  • Biosense Webster, Inc.
  • CardioFocus, Inc.
  • CathEffects Inc.
  • CathRx Ltd.
  • EndoPhotonix, Inc.
  • Japan Lifeline Co.
  • Osypka AG
  • Pioneer Medical Devices AG
  • GE Healthcare
  • TZ Medical, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Atrial Fibrillation Market:

  • In April 2021, according to a statement from Tempus, the US Food and Drug Administration designated the company's ECG Analysis Platform as a breakthrough device. By using technologies developed in partnership with Geisinger, clinicians may more quickly identify patients who are more prone to encounter atrial fibrillation (AF) or atrial flutter.

The global atrial fibrillation market is driven by various factors, including the rising prevalence of AF, the increasing geriatric population, technological advancements, and the growing demand for minimally invasive procedures. The prevalence of AF is increasing globally, mainly due to the aging population and lifestyle changes such as sedentary behavior, smoking, and excessive alcohol consumption. According to the Centers for Disease Control and Prevention (CDC), AF affects an estimated 2.7-6.1 million people in the United States alone, and the prevalence is expected to rise in the coming years. The increasing geriatric population is another major factor driving the growth of the atrial fibrillation market. Aging is a significant risk factor for AF, and the aging population is growing rapidly worldwide. According to the World Health Organization (WHO), the worldwide population of individuals aged 60 and more is predicted to reach 2 billion by 2050. Technological breakthroughs have resulted in the development of various innovative treatment options for AF. For instance, catheter ablation, a minimally invasive procedure that uses radiofrequency or cryotherapy to destroy abnormal heart tissue causing AF, has gained popularity in recent years. The demand for catheter ablation is expected to increase due to its effectiveness and safety compared to traditional treatment options such as anti-arrhythmic drugs. The rising demand for minimally invasive operations is also influencing the growth of the atrial fibrillation market. Minimally invasive procedures offer several advantages, such as shorter hospital stays, fewer complications, and quicker recovery times. The demand for minimally invasive procedures is expected to increase due to the growing patient preference for such procedures.

However, the high cost of treatment and the shortage of skilled healthcare professionals may hinder the growth of the atrial fibrillation market. The high cost of treatment can be a significant barrier for patients with limited financial resources, particularly in low- and middle-income countries. The shortage of skilled healthcare professionals may also limit access to specialized care for AF patients, especially in rural and remote areas.

Overall, the atrial fibrillation market is anticipated to grow in the years to come due to the increasing prevalence of AF and the growing demand for effective and minimally invasive treatment options. The market players are focusing on developing innovative products and technologies to cater to the unmet needs of AF patients and improve the outcomes of AF treatment.

By Type

  • Surgical Devices
    • Maze Surgery
    • Catheter Ablation
    • Radiofrequency Catheter Ablation
      • Conventional RF Ablation Catheters
      • Irrigated-tip RF Ablation Catheters
    • Cryoablation
    • Microwave Based Catheter Ablation
    • Laser Based Catheter Ablation
    • Navigational Advanced Mapping Accessories
  • Non-Surgical Devices
    • Electric Cardioversion
    • Diagnostic Catheters
    • Conventional Diagnostic Catheters
      • Fixed Diagnostic Catheters
      • Steerable Diagnostic Catheters
    • Advanced Diagnostic Catheters
    • Mapping and Recording Systems
    • Cardiac Monitors
    • Access Devices
    • Left Atrial Appendage and Closure Devices
    • Intracardiac Echocardiography (ICE) Systems

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the largest share in the global market in 2022. This is mostly due to the growing patient population in the region and the presence of major participants. The United States is anticipated to dominate market expansion in the North American region. According to statistics provided by the CDC, in September 2021, it was estimated that 12.1 million Americans would have atrial fibrillation by 2030. With the growing geriatric population, demand for the Atrial fibrillation market is anticipated to increase in the coming years. Additionally, based on Type; surgical segment, held the highest revenue share in 2022.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Atrial Fibrillation Market By Type and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Atrial Fibrillation Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Atrial Fibrillation Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Atrial Fibrillation Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Atrial Fibrillation Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Surgical Devices
         1.1. Maze Surgery
         1.2. Catheter Ablation
         1.3. Radiofrequency Catheter Ablation
          1.3.1. Conventional RF Ablation Catheters
          1.3.2. Irrigated-tip RF Ablation Catheters
         1.4. Cryoablation
         1.5. Microwave Based Catheter Ablation
         1.6. Laser Based Catheter Ablation
         1.7. Navigational Advanced Mapping Accessories
        2. Non-Surgical Devices
         2.1. Electric Cardioversion
         2.2. Diagnostic Catheters
         2.3. Conventional Diagnostic Catheters
          2.3.1. Fixed Diagnostic Catheters
          2.3.2. Steerable Diagnostic Catheters
         2.4. Advanced Diagnostic Catheters
         2.5. Mapping and Recording Systems
         2.6. Cardiac Monitors
         2.7. Access Devices
         2.8. Left Atrial Appendage and Closure Devices
         2.9. Intracardiac Echocardiography (ICE) Systems

  • 8.   North America Atrial Fibrillation Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 9.   Latin America Atrial Fibrillation Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 10.   Europe Atrial Fibrillation Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 11.   Asia Pacific Atrial Fibrillation Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 12.   Middle East and Africa Atrial Fibrillation Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 13.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 14.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Johnson And Johnson
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. MicroPort Scientific Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Boston Scientific Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. BCN Peptides S.A.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. St. Jude Medical, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medtronic plc
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Biotronik SECo. KG
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Koninklijke Philips N.V.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Siemens AG
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.AtriCure Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Biosense Webster, Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. CardioFocus, Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. CathEffects Inc.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. CathRx Ltd.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. EndoPhotonix, Inc.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Japan Lifeline Co.
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Osypka AG
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Pioneer Medical Devices AG
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. GE Healthcare
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. TZ Medical, Inc.
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview

  • 15.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 16.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11